Cytek Biosciences, Inc. (CTKB)
4.675
+0.06
(+1.19%)
USD |
NASDAQ |
Sep 09, 13:52
Cytek Biosciences Price to Book Value : 1.887 for Sept. 9, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 1.865 |
| September 04, 2026 | 1.898 |
| September 03, 2026 | 1.898 |
| September 02, 2026 | 1.894 |
| September 01, 2026 | 1.865 |
| August 31, 2026 | 1.930 |
| August 28, 2026 | 1.890 |
| August 27, 2026 | 1.865 |
| August 26, 2026 | 1.845 |
| August 25, 2026 | 1.849 |
| August 24, 2026 | 1.793 |
| August 21, 2026 | 1.942 |
| August 20, 2026 | 1.881 |
| August 19, 2026 | 1.898 |
| August 18, 2026 | 1.885 |
| August 17, 2026 | 1.914 |
| August 14, 2026 | 1.894 |
| August 13, 2026 | 1.974 |
| August 12, 2026 | 1.930 |
| August 11, 2026 | 1.914 |
| August 10, 2026 | 1.881 |
| August 07, 2026 | 1.696 |
| August 06, 2026 | 1.680 |
| August 05, 2026 | 1.688 |
| August 04, 2026 | 1.728 |
| Date | Value |
|---|---|
| August 03, 2026 | 1.740 |
| July 31, 2026 | 1.704 |
| July 30, 2026 | 1.740 |
| July 29, 2026 | 1.768 |
| July 28, 2026 | 1.801 |
| July 27, 2026 | 1.780 |
| July 24, 2026 | 1.801 |
| July 23, 2026 | 1.841 |
| July 22, 2026 | 1.833 |
| July 21, 2026 | 1.845 |
| July 20, 2026 | 1.849 |
| July 17, 2026 | 1.865 |
| July 16, 2026 | 1.873 |
| July 15, 2026 | 1.877 |
| July 14, 2026 | 1.865 |
| July 13, 2026 | 1.821 |
| July 10, 2026 | 1.865 |
| July 09, 2026 | 1.853 |
| July 08, 2026 | 1.772 |
| July 07, 2026 | 1.841 |
| July 06, 2026 | 1.865 |
| July 02, 2026 | 1.853 |
| July 01, 2026 | 1.849 |
| June 30, 2026 | 1.788 |
| June 29, 2026 | 1.711 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Agilent Technologies, Inc. | 5.558 |
| Bio-Rad Laboratories, Inc. | 1.404 |
| Bruker Corp. | 3.472 |
| Danaher Corp. | 2.738 |
| Harvard Bioscience, Inc. | 4.959 |
Price to Book Value Related Metrics
| PS Ratio | 2.905 |
| PEG Ratio | -0.0066 |
| Price | 4.675 |
| Earnings Yield | -13.42% |
| Market Cap | 607.67M |
| PEGY Ratio | -0.0066 |